Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Varga

Showing results (261-270 of 389) with videos related to

Pageof 39
Sort By:
The American Journal of Case Reports|December 20, 2023
Anesthetic Management of Coronary Artery Bypass Grafting in a Patient with Charcot-Marie-Tooth Disease and Multivessel Coronary Artery DiseaseJoshua Rawson, J W Awori Hayanga, Jessica L Varga, et al.
Archives of Biochemistry and Biophysics|November 15, 1996
Ca(2+)- and Al(3+)-induced conformational transitions of amyloid fragment H-Ile-Ile-Gly-Leu-Met-NH2I Laczkó, E Vass, K Soós, et al.
Gut|July 1, 1994
Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazoleA Schmassmann, A Tarnawski, H A Gerber, et al.
Journal of Cancer Research and Clinical Oncology|November 17, 2001
Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptideI Chatzistamou, A V Schally, J L Varga, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogsHippokratis Kiaris, Andrew V Schally, Rebeca Busto, et al.
Gut|February 1, 1994
Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the ratA Schmassmann, A Garner, B Flogerzi, et al.
Zeitschrift Fur Gastroenterologie|March 1, 1983
[Addition of albumin to solutions of cholecystokinin (CCK)--effect on pancreatic secretion, plasma CCK level and release of pancreatic polypeptide (PP)]M Fried, K Gyr, C Beglinger, et al.
Diagnostic and Clinical Immunology|January 1, 1987
Study of the immune complex precipitation-inhibiting capacity of sera of patients with chronic lymphocytic leukaemiaL Varga, Z Miszlay, E Czink, et al.
Complement (Basel, Switzerland)|January 1, 1988
Patients with CLL and hypocomplementaemia have an impaired serum bactericidal activity against the Salmonella minnesota Re mutantL Varga, F Clas, G Füst, et al.
Acta Medica Hungarica|January 1, 1986
Repressed classical complement pathway activities and clinical correlations in chronic lymphocytic leukaemiaZ Miszlai, E Czink, L Varga, et al.
Pageof 39

Showing results (261-270 of 389) with videos related to

Sort By:
Pageof 39
The American Journal of Case Reports|December 20, 2023
Anesthetic Management of Coronary Artery Bypass Grafting in a Patient with Charcot-Marie-Tooth Disease and Multivessel Coronary Artery DiseaseJoshua Rawson, J W Awori Hayanga, Jessica L Varga, et al.
Archives of Biochemistry and Biophysics|November 15, 1996
Ca(2+)- and Al(3+)-induced conformational transitions of amyloid fragment H-Ile-Ile-Gly-Leu-Met-NH2I Laczkó, E Vass, K Soós, et al.
Gut|July 1, 1994
Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazoleA Schmassmann, A Tarnawski, H A Gerber, et al.
Journal of Cancer Research and Clinical Oncology|November 17, 2001
Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptideI Chatzistamou, A V Schally, J L Varga, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogsHippokratis Kiaris, Andrew V Schally, Rebeca Busto, et al.
Gut|February 1, 1994
Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the ratA Schmassmann, A Garner, B Flogerzi, et al.
Zeitschrift Fur Gastroenterologie|March 1, 1983
[Addition of albumin to solutions of cholecystokinin (CCK)--effect on pancreatic secretion, plasma CCK level and release of pancreatic polypeptide (PP)]M Fried, K Gyr, C Beglinger, et al.
Diagnostic and Clinical Immunology|January 1, 1987
Study of the immune complex precipitation-inhibiting capacity of sera of patients with chronic lymphocytic leukaemiaL Varga, Z Miszlay, E Czink, et al.
Complement (Basel, Switzerland)|January 1, 1988
Patients with CLL and hypocomplementaemia have an impaired serum bactericidal activity against the Salmonella minnesota Re mutantL Varga, F Clas, G Füst, et al.
Acta Medica Hungarica|January 1, 1986
Repressed classical complement pathway activities and clinical correlations in chronic lymphocytic leukaemiaZ Miszlai, E Czink, L Varga, et al.
Pageof 39